TALAZOPARIB

TALAZOPARIB was reported 1853 times

TALAZOPARIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROSTATE SARCOMA 1 0.2500
1 CHECKPOINT KINASE 2 GENE MUTATION 1 0.1429
2 OVARIAN SERTOLI-LEYDIG CELL TUMOUR 1 0.1250
3 URINE URIC ACID DECREASED 1 0.1111
4 LACTATE DEHYDROGENASE URINE INCREASED 1 0.1111
5 PROCALCITONIN DECREASED 3 0.0429
6 ACQUIRED SYRINGOMYELIA 1 0.0385
7 RADIATION DYSPHAGIA 1 0.0238
8 HEAD AND NECK CANCER METASTATIC 1 0.0238
9 PLATELET PRODUCTION DECREASED 1 0.0189
10 ACUTE MONOCYTIC LEUKAEMIA 3 0.0165
11 ACUTE ERYTHROID LEUKAEMIA 1 0.0159
12 CHLOROPSIA 2 0.0156
13 BRCA1 GENE MUTATION 1 0.0114
14 METASTASES TO SKIN 11 0.0106
15 BRCA2 GENE MUTATION 1 0.0105
16 BONE MARROW INFILTRATION 4 0.0103
17 SPLENIC EMBOLISM 1 0.0087
18 COLD FLASH 1 0.0086
19 PERFORATION BILE DUCT 1 0.0077
20 MYELODYSPLASTIC SYNDROME TRANSFORMATION 4 0.0077
21 CERVIX NEOPLASM 1 0.0073
22 BLADDER TAMPONADE 2 0.0066
23 BLOOD CREATININE 1 0.0065
24 PROSTATIC HAEMORRHAGE 2 0.0063
25 BONE HYPERTROPHY 1 0.0062
26 BLOOD URIC ACID DECREASED 3 0.0062
27 THYROID PAIN 1 0.0056
28 CYSTITIS RADIATION 1 0.0052
29 METASTASES TO SPINAL CORD 1 0.0052
30 PENILE INFECTION 1 0.0052
31 HAEMATOTOXICITY 48 0.0050
32 NEOPLASM PROGRESSION 171 0.0049
33 PERIPHERAL CIRCULATORY FAILURE 2 0.0049
34 SCROTAL INFECTION 1 0.0048
35 SECOND PRIMARY MALIGNANCY 39 0.0047
36 SOMATIC SYMPTOM DISORDER 5 0.0046
37 IRON BINDING CAPACITY TOTAL DECREASED 1 0.0045
38 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
39 PLEURAL INFECTION 1 0.0043
40 SWEAT GLAND TUMOUR 1 0.0043
41 MONOCYTE PERCENTAGE INCREASED 3 0.0042
42 PERIPHERAL VEIN THROMBOSIS 1 0.0042
43 STOMA SITE ABSCESS 1 0.0041
44 MYELOID LEUKAEMIA 2 0.0040
45 BURNING FEET SYNDROME 1 0.0040
46 METASTASES TO THORAX 1 0.0040
47 CARBOHYDRATE ANTIGEN 15-3 INCREASED 3 0.0039
48 ESCHERICHIA PYELONEPHRITIS 1 0.0039
49 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
50 METASTASES TO NECK 1 0.0036
51 AUTOIMMUNE NEUTROPENIA 1 0.0035
52 ERYTHROPOIESIS ABNORMAL 1 0.0033
53 ENTEROCOLITIS INFECTIOUS 3 0.0033
54 HAEMATOLOGY TEST ABNORMAL 1 0.0031
55 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 2 0.0030
56 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
57 PROSTATIC SPECIFIC ANTIGEN INCREASED 41 0.0030
58 ANION GAP DECREASED 1 0.0029
59 LIVER FUNCTION TEST DECREASED 1 0.0028
60 BLOOD FOLATE DECREASED 2 0.0028
61 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 1 0.0027
62 THROMBOTIC CEREBRAL INFARCTION 1 0.0027
63 PROSTATIC SPECIFIC ANTIGEN DECREASED 1 0.0026
64 HERPES SIMPLEX REACTIVATION 1 0.0026
65 RADIATION OESOPHAGITIS 1 0.0026
66 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
67 ADRENAL GLAND CANCER 1 0.0026
68 SQUAMOUS CELL CARCINOMA OF THE TONGUE 1 0.0024
69 MEAN CELL HAEMOGLOBIN INCREASED 4 0.0024
70 BONE FISSURE 1 0.0024
71 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
72 ABDOMINAL CAVITY DRAINAGE 1 0.0024
73 GLUCOCORTICOID DEFICIENCY 1 0.0024
74 OVARIAN CANCER METASTATIC 2 0.0024
75 DIABETIC HYPEROSMOLAR COMA 1 0.0023
76 DEGENERATIVE BONE DISEASE 1 0.0023
77 TUMOUR MARKER INCREASED 10 0.0021
78 MOTOR NEURONE DISEASE 1 0.0021
79 DRAINAGE 1 0.0020
80 BREAST CANCER MALE 1 0.0020
81 ACCIDENT AT HOME 1 0.0019
82 EMBOLISM 16 0.0019
83 HYPHAEMA 1 0.0019
84 RETINAL VASCULAR THROMBOSIS 1 0.0019
85 HYPERTENSIVE URGENCY 1 0.0018
86 PROSTATE CANCER METASTATIC 6 0.0018
87 ADRENAL HAEMORRHAGE 1 0.0018
88 METASTASES TO BONE 29 0.0018
89 RADIATION NECROSIS 1 0.0017
90 HORMONE-REFRACTORY PROSTATE CANCER 2 0.0017
91 BLEEDING TIME PROLONGED 2 0.0017
92 MEAN PLATELET VOLUME INCREASED 1 0.0017
93 SITTING DISABILITY 1 0.0016
94 TROPONIN T INCREASED 2 0.0016
95 MEAN CELL VOLUME INCREASED 4 0.0016
96 HYPOTRICHOSIS 1 0.0016
97 CYTOPENIA 19 0.0016
98 SUSPECTED OFF LABEL USE 7 0.0015
99 PNEUMONIA NECROTISING 1 0.0015
100 ANAEMIA 285 0.0015
101 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
102 HEAD AND NECK CANCER 1 0.0015
103 VENTRICULAR ARRHYTHMIA 5 0.0014
104 METASTASES TO LIVER 23 0.0013
105 OBSTRUCTIVE PANCREATITIS 1 0.0013
106 BILIRUBIN CONJUGATED INCREASED 3 0.0013
107 PANCYTOPENIA 71 0.0013
108 HEPATITIS VIRAL 1 0.0012
109 OVARIAN CANCER RECURRENT 2 0.0012
110 LYMPHANGITIS 1 0.0012
111 ACUTE LEUKAEMIA 2 0.0012
112 HYDROTHORAX 1 0.0012
113 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
114 TROPONIN I INCREASED 2 0.0012
115 NEOPLASM RECURRENCE 4 0.0012
116 ABDOMINAL LYMPHADENOPATHY 1 0.0012
117 SPINAL CORD INJURY 2 0.0011
118 FULL BLOOD COUNT DECREASED 23 0.0011
119 HILAR LYMPHADENOPATHY 1 0.0011
120 BLOOD MAGNESIUM INCREASED 1 0.0011
121 MYELODYSPLASTIC SYNDROME 16 0.0011
122 HEART TRANSPLANT 1 0.0011
123 METASTASES TO ADRENALS 1 0.0011
124 ABULIA 1 0.0011
125 FEBRILE NEUTROPENIA 71 0.0011
126 INTRACRANIAL MASS 1 0.0011
127 CANCER SURGERY 1 0.0010
128 BONE SWELLING 1 0.0010
129 BLOOD IRON ABNORMAL 1 0.0010
130 DEVICE RELATED THROMBOSIS 1 0.0010
131 GENE MUTATION 2 0.0010
132 ATYPICAL PNEUMONIA 3 0.0010
133 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 1 0.0010
134 BLOOD CREATININE DECREASED 3 0.0010
135 METASTASES TO LUNG 11 0.0010
136 FEBRILE BONE MARROW APLASIA 4 0.0009
137 RADIATION INJURY 1 0.0009
138 ANAEMIA MACROCYTIC 2 0.0009
139 BLOOD TESTOSTERONE INCREASED 2 0.0009
140 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
141 LARYNGEAL CANCER 1 0.0009
142 THROMBOCYTOPENIA 100 0.0009
143 MYOCARDIAL INJURY 1 0.0009
144 METASTASES TO MENINGES 2 0.0009
145 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
146 RED BLOOD CELL COUNT DECREASED 25 0.0009
147 PRURITUS ALLERGIC 1 0.0009
148 EMBOLIC STROKE 3 0.0009
149 FULL BLOOD COUNT ABNORMAL 9 0.0009
150 BREAST CANCER METASTATIC 9 0.0008
151 BRONCHIAL HYPERREACTIVITY 1 0.0008
152 HAEMOGLOBIN DECREASED 85 0.0008
153 FRACTURED SACRUM 1 0.0008
154 HYPERNATRAEMIA 4 0.0008
155 BLOOD BILIRUBIN ABNORMAL 1 0.0008
156 MALIGNANT NEOPLASM PROGRESSION 80 0.0008
157 BILIARY OBSTRUCTION 1 0.0008
158 FAILURE TO THRIVE 4 0.0008
159 ACUTE MYELOID LEUKAEMIA 12 0.0008
160 ACQUIRED GENE MUTATION 1 0.0008
161 EXFOLIATIVE RASH 2 0.0008
162 LUNG OPACITY 2 0.0008
163 PACKED RED BLOOD CELL TRANSFUSION 1 0.0008
164 BLOOD SODIUM INCREASED 2 0.0007
165 PLATELET COUNT DECREASED 79 0.0007
166 VIRAEMIA 1 0.0007
167 PROTHROMBIN TIME SHORTENED 1 0.0007
168 PERIPHERAL ARTERY OCCLUSION 1 0.0007
169 NEUTROPENIC SEPSIS 5 0.0007
170 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
171 GASTROINTESTINAL WALL THICKENING 1 0.0007
172 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
173 NEUTROPHIL COUNT DECREASED 27 0.0007
174 BONE MARROW DISORDER 2 0.0007
175 MYOCLONIC EPILEPSY 1 0.0007
176 INFECTIOUS PLEURAL EFFUSION 1 0.0007
177 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
178 MEAN CELL VOLUME DECREASED 1 0.0006
179 VASCULAR RUPTURE 1 0.0006
180 PERFORMANCE STATUS DECREASED 3 0.0006
181 BACTERIAL VAGINOSIS 1 0.0006
182 NON-CARDIAC CHEST PAIN 2 0.0006
183 BILE DUCT STONE 2 0.0006
184 COLON CANCER METASTATIC 1 0.0006
185 SPINAL CORD DISORDER 1 0.0006
186 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
187 METASTASES TO LYMPH NODES 4 0.0006
188 LYMPHOEDEMA 4 0.0006
189 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
190 FOOD INTERACTION 1 0.0006
191 GASTROINTESTINAL OEDEMA 1 0.0006
192 PARAPARESIS 1 0.0006
193 HAEMATOCRIT DECREASED 11 0.0006
194 PNEUMOMEDIASTINUM 1 0.0006
195 MONOPARESIS 1 0.0006
196 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
197 ESSENTIAL HYPERTENSION 1 0.0005
198 FOOD INTOLERANCE 2 0.0005
199 HYDRONEPHROSIS 4 0.0005
200 BONE MARROW TRANSPLANT 1 0.0005
201 GASTRIC INFECTION 2 0.0005
202 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
203 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
204 EMPYEMA 1 0.0005
205 IMMUNE-MEDIATED HEPATITIS 1 0.0005
206 ACUTE CORONARY SYNDROME 4 0.0005
207 BLOOD BILIRUBIN INCREASED 13 0.0005
208 TRANSFUSION 5 0.0005
209 MYELOSUPPRESSION 17 0.0005
210 CD4 LYMPHOCYTES DECREASED 1 0.0005
211 HAEMOGLOBIN ABNORMAL 3 0.0005
212 NEUTROPENIA 63 0.0005
213 PERIODONTITIS 1 0.0005
214 LEUKOPENIA 23 0.0005
215 APPETITE DISORDER 3 0.0005
216 FAECES PALE 1 0.0004
217 SENSORY DISTURBANCE 7 0.0004
218 LICHEN PLANUS 1 0.0004
219 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
220 PULMONARY INFARCTION 1 0.0004
221 METASTASIS 3 0.0004
222 MYOPIA 1 0.0004
223 HYPOVOLAEMIC SHOCK 2 0.0004
224 HAEMATOLOGICAL INFECTION 1 0.0004
225 RETROPERITONEAL HAEMORRHAGE 1 0.0004
226 ACUTE PSYCHOSIS 1 0.0004
227 PNEUMONITIS 11 0.0004
228 METASTASES TO PERITONEUM 1 0.0004
229 BLOOD COUNT ABNORMAL 6 0.0004
230 DYSLIPIDAEMIA 2 0.0004
231 HAEMORRHAGE URINARY TRACT 1 0.0004
232 PHYSICAL DECONDITIONING 1 0.0004
233 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
234 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
235 ATRIAL FLUTTER 3 0.0004
236 LIP BLISTER 1 0.0004
237 SUBDURAL HAEMORRHAGE 1 0.0004
238 MACULE 1 0.0004
239 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
240 TRICHORRHEXIS 1 0.0004
241 INTERMENSTRUAL BLEEDING 2 0.0004
242 BLOOD TEST ABNORMAL 5 0.0004
243 NEUTROPHIL COUNT ABNORMAL 1 0.0004
244 HEPATOCELLULAR INJURY 5 0.0004
245 HAEMATURIA 12 0.0004
246 TUMOUR HAEMORRHAGE 1 0.0004
247 VITAMIN B12 DECREASED 1 0.0003
248 PARAPLEGIA 1 0.0003
249 ENTEROCOLITIS 2 0.0003
250 HYPERTONIC BLADDER 1 0.0003
251 PYELONEPHRITIS 3 0.0003
252 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
253 NECK INJURY 1 0.0003
254 LYMPHOCYTE COUNT DECREASED 6 0.0003
255 ODYNOPHAGIA 2 0.0003
256 PLATELET COUNT ABNORMAL 2 0.0003
257 MYELOFIBROSIS 1 0.0003
258 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
259 SMALL INTESTINAL OBSTRUCTION 4 0.0003
260 LEUKAEMIA 3 0.0003
261 COLITIS 12 0.0003
262 DISEASE PROGRESSION 37 0.0003
263 HYPOXIA 11 0.0003
264 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
265 THROMBOTIC MICROANGIOPATHY 3 0.0003
266 WALKING AID USER 2 0.0003
267 NEAR DEATH EXPERIENCE 1 0.0003
268 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
269 CARDIAC FAILURE ACUTE 2 0.0003
270 LYME DISEASE 1 0.0003
271 MENINGITIS 2 0.0003
272 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
273 HEPATIC CYST 1 0.0003
274 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
275 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
276 BLOOD TESTOSTERONE DECREASED 2 0.0003
277 APLASIA PURE RED CELL 1 0.0003
278 ONYCHOCLASIS 2 0.0003
279 VENTRICULAR EXTRASYSTOLES 3 0.0003
280 GRANULOMA 1 0.0003
281 WEIGHT FLUCTUATION 3 0.0003
282 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
283 RESTLESS LEGS SYNDROME 5 0.0003
284 AMYLASE INCREASED 1 0.0003
285 CEREBRAL DISORDER 2 0.0003
286 HAEMORRHAGE INTRACRANIAL 4 0.0003
287 HYPONATRAEMIA 15 0.0003
288 PROTEIN TOTAL DECREASED 1 0.0003
289 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
290 HYPOKALAEMIA 12 0.0003
291 SPINAL CORD COMPRESSION 1 0.0003
292 BRAIN FOG 4 0.0003
293 TORSADE DE POINTES 2 0.0003
294 LYMPHADENOPATHY 9 0.0003
295 PNEUMONIA FUNGAL 1 0.0003
296 OESOPHAGEAL PAIN 1 0.0003
297 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
298 BLOOD ALBUMIN DECREASED 2 0.0003
299 OBSTRUCTION 1 0.0003
300 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
301 CYSTITIS HAEMORRHAGIC 1 0.0002
302 VITAMIN B12 DEFICIENCY 1 0.0002
303 TASTE DISORDER 5 0.0002
304 BONE MARROW FAILURE 5 0.0002
305 GOITRE 1 0.0002
306 SPINAL STENOSIS 1 0.0002
307 PULMONARY EMBOLISM 23 0.0002
308 EOSINOPHIL COUNT INCREASED 2 0.0002
309 DYSPNOEA EXERTIONAL 9 0.0002
310 BLOOD UREA INCREASED 4 0.0002
311 ONYCHOMADESIS 1 0.0002
312 BRAIN OEDEMA 3 0.0002
313 BUNDLE BRANCH BLOCK LEFT 1 0.0002
314 HEPATIC CYTOLYSIS 3 0.0002
315 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
316 UTERINE HAEMORRHAGE 1 0.0002
317 HEPATIC PAIN 1 0.0002
318 HEPATIC LESION 1 0.0002
319 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
320 PLATELET COUNT INCREASED 3 0.0002
321 SEPTIC SHOCK 10 0.0002
322 TONGUE DISCOLOURATION 1 0.0002
323 NAIL DISORDER 2 0.0002
324 MELANOCYTIC NAEVUS 1 0.0002
325 PARONYCHIA 1 0.0002
326 BLOOD CREATINE INCREASED 1 0.0002
327 DEATH 194 0.0002
328 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
329 ISCHAEMIC STROKE 4 0.0002
330 LOSS OF LIBIDO 2 0.0002
331 IRON DEFICIENCY 1 0.0002
332 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
333 HYPERGLYCAEMIA 8 0.0002
334 DISEASE COMPLICATION 1 0.0002
335 OVARIAN CANCER 2 0.0002
336 PERICARDIAL EFFUSION 5 0.0002
337 THERAPY CESSATION 11 0.0002
338 FLANK PAIN 2 0.0002
339 TIBIA FRACTURE 1 0.0002
340 ARTERIOSCLEROSIS 2 0.0002
341 BLOOD SODIUM DECREASED 4 0.0002
342 CARDIAC TAMPONADE 1 0.0002
343 PRODUCT PRESCRIBING ERROR 5 0.0002
344 AFFECT LABILITY 2 0.0002
345 APATHY 3 0.0002
346 THERAPY CHANGE 2 0.0002
347 HOSPICE CARE 2 0.0002
348 ORGANISING PNEUMONIA 1 0.0002
349 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
350 SEPSIS 22 0.0002
351 SLUGGISHNESS 2 0.0002
352 FEMORAL NECK FRACTURE 1 0.0002
353 CEREBRAL ISCHAEMIA 1 0.0002
354 C-REACTIVE PROTEIN INCREASED 7 0.0002
355 PARTIAL SEIZURES 1 0.0002
356 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
357 SUDDEN DEATH 2 0.0002
358 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
359 BLOOD POTASSIUM INCREASED 3 0.0002
360 PRODUCT DISPENSING ERROR 4 0.0002
361 JAW DISORDER 1 0.0002
362 NONSPECIFIC REACTION 1 0.0002
363 URINARY RETENTION 6 0.0002
364 HEART RATE ABNORMAL 1 0.0002
365 ACUTE PULMONARY OEDEMA 1 0.0002
366 BLOOD CALCIUM DECREASED 2 0.0002
367 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
368 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
369 CHOLECYSTITIS ACUTE 1 0.0002
370 FATIGUE 137 0.0002
371 NEUROLOGICAL SYMPTOM 1 0.0002
372 MUSCULOSKELETAL DISCOMFORT 3 0.0002
373 EXERCISE TOLERANCE DECREASED 1 0.0002
374 MADAROSIS 2 0.0002
375 SPINAL PAIN 2 0.0002
376 ASCITES 5 0.0002
377 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
378 ACUTE MYOCARDIAL INFARCTION 5 0.0002
379 BRADYKINESIA 1 0.0002
380 COVID-19 PNEUMONIA 2 0.0002
381 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
382 CHOLECYSTITIS 2 0.0002
383 ASTHENIA 63 0.0002
384 HEPATIC FAILURE 5 0.0002
385 LEUKOCYTOSIS 3 0.0002
386 BONE DISORDER 3 0.0002
387 HYPOACUSIS 7 0.0002
388 CHOLANGITIS 1 0.0002
389 AGEUSIA 4 0.0002
390 FRACTURE 3 0.0002
391 PROCTALGIA 1 0.0002
392 ORAL HERPES 3 0.0002
393 BEDRIDDEN 2 0.0002
394 CORONAVIRUS INFECTION 1 0.0002
395 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
396 MALIGNANT MELANOMA 2 0.0001
397 BREAST MASS 1 0.0001
398 DECREASED APPETITE 34 0.0001
399 ACUTE HEPATIC FAILURE 2 0.0001
400 DROOLING 1 0.0001
401 INTERSTITIAL LUNG DISEASE 7 0.0001
402 AUTOIMMUNE HEPATITIS 1 0.0001
403 HYPOMAGNESAEMIA 2 0.0001
404 COORDINATION ABNORMAL 2 0.0001
405 RIGHT VENTRICULAR FAILURE 1 0.0001
406 PULMONARY TOXICITY 1 0.0001
407 THERAPY INTERRUPTED 10 0.0001
408 GRAFT VERSUS HOST DISEASE 1 0.0001
409 DEEP VEIN THROMBOSIS 9 0.0001
410 VISUAL FIELD DEFECT 1 0.0001
411 PRODUCT PRESCRIBING ISSUE 3 0.0001
412 FAECES SOFT 1 0.0001
413 RASH PUSTULAR 1 0.0001
414 MOUTH HAEMORRHAGE 1 0.0001
415 PSYCHIATRIC SYMPTOM 1 0.0001
416 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
417 HEPATOTOXICITY 3 0.0001
418 PULMONARY MASS 2 0.0001
419 PAROSMIA 1 0.0001
420 TROPONIN INCREASED 1 0.0001
421 ACIDOSIS 1 0.0001
422 SYNCOPE 13 0.0001
423 EJECTION FRACTION DECREASED 2 0.0001
424 HYPOALBUMINAEMIA 1 0.0001
425 PELVIC FRACTURE 1 0.0001
426 PULMONARY HAEMORRHAGE 1 0.0001
427 GASTROINTESTINAL INFLAMMATION 1 0.0001
428 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
429 FURUNCLE 1 0.0001
430 PNEUMOTHORAX 2 0.0001
431 GINGIVAL PAIN 1 0.0001
432 FRUSTRATION TOLERANCE DECREASED 1 0.0001
433 PNEUMONIA 40 0.0001
434 SHOCK HAEMORRHAGIC 1 0.0001
435 HYPERAESTHESIA 1 0.0001
436 VENTRICULAR TACHYCARDIA 2 0.0001
437 SPINAL COMPRESSION FRACTURE 1 0.0001
438 SKIN DISORDER 4 0.0001
439 GAIT INABILITY 4 0.0001
440 FACIAL PARALYSIS 1 0.0001
441 CARDIAC OPERATION 1 0.0001
442 DYSPHAGIA 11 0.0001
443 NEUROPATHY PERIPHERAL 11 0.0001
444 MUSCLE STRAIN 1 0.0001
445 OFF LABEL USE 101 0.0001
446 RESPIRATORY TRACT INFECTION 3 0.0001
447 HAEMORRHAGE 12 0.0001
448 MUCOSAL INFLAMMATION 3 0.0001
449 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
450 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
451 PROSTATE CANCER 9 0.0001
452 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
453 HAEMOLYTIC ANAEMIA 1 0.0001
454 ANAL INCONTINENCE 1 0.0001
455 PNEUMONIA BACTERIAL 1 0.0001
456 BRAIN NEOPLASM 1 0.0001
457 UROSEPSIS 1 0.0001
458 IRON DEFICIENCY ANAEMIA 1 0.0001
459 AGRANULOCYTOSIS 2 0.0001
460 HAEMOPTYSIS 3 0.0001
461 HEPATIC ENCEPHALOPATHY 1 0.0001
462 COGNITIVE DISORDER 5 0.0001
463 APPENDICITIS 1 0.0001
464 ALOPECIA 21 0.0001
465 SQUAMOUS CELL CARCINOMA 1 0.0001
466 HOT FLUSH 8 0.0001
467 HYPOCALCAEMIA 2 0.0001
468 FEELING JITTERY 2 0.0001
469 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
470 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
471 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
472 HERNIA 2 0.0001
473 BONE PAIN 6 0.0001
474 LABORATORY TEST ABNORMAL 3 0.0001
475 URINARY INCONTINENCE 3 0.0001
476 DRUG INTERACTION 16 0.0001
477 BLOOD POTASSIUM DECREASED 3 0.0001
478 STOMATITIS 6 0.0001
479 PLEURAL EFFUSION 6 0.0001
480 PYREXIA 34 0.0001
481 MOTOR DYSFUNCTION 1 0.0001
482 BODY TEMPERATURE INCREASED 2 0.0001
483 EAR DISCOMFORT 1 0.0001
484 EMOTIONAL DISORDER 3 0.0001
485 HELICOBACTER INFECTION 1 0.0001
486 ILLNESS 10 0.0001
487 MUSCULAR WEAKNESS 11 0.0001
488 NERVOUS SYSTEM DISORDER 3 0.0001
489 TENDERNESS 1 0.0001
490 POLLAKIURIA 4 0.0001
491 UNDERDOSE 7 0.0001
492 PETECHIAE 1 0.0001
493 INCONTINENCE 1 0.0001
494 DYSGEUSIA 7 0.0001
495 HYPOTHYROIDISM 3 0.0001
496 BREAST PAIN 1 0.0001
497 BODY HEIGHT DECREASED 1 0.0001
498 DECREASED ACTIVITY 1 0.0001
499 ATRIAL FIBRILLATION 9 0.0001
500 PULMONARY THROMBOSIS 1 0.0001
501 OESOPHAGITIS 1 0.0001
502 ASPIRATION 1 0.0001
503 GASTROINTESTINAL PAIN 1 0.0001
504 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
505 HYPERTENSIVE CRISIS 1 0.0001
506 HYPOTENSION 18 0.0001
507 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
508 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
509 CHROMATURIA 2 0.0001
510 CEREBROVASCULAR ACCIDENT 15 0.0001
511 DYSPNOEA 50 0.0001
512 MYOCARDIAL ISCHAEMIA 1 0.0001
513 MICTURITION URGENCY 1 0.0001
514 CHOLECYSTECTOMY 1 0.0001
515 MYOCARDITIS 1 0.0001
516 CARDIAC FAILURE 7 0.0001
517 THROMBOSIS 7 0.0001
518 SEIZURE 10 0.0001
519 CARDIAC ARREST 7 0.0001
520 NAUSEA 67 0.0001
521 BLOOD IRON DECREASED 1 0.0001
522 BACTERAEMIA 1 0.0001
523 HYPERLIPIDAEMIA 1 0.0001
524 ADRENAL INSUFFICIENCY 1 0.0001
525 WEIGHT DECREASED 23 0.0001
526 RESPIRATORY FAILURE 6 0.0001
527 DIZZINESS 41 0.0001
528 VERTIGO 5 0.0001
529 CEREBRAL INFARCTION 2 0.0001
530 ABDOMINAL PAIN 19 0.0001
531 DYSURIA 3 0.0001
532 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
533 DYSPEPSIA 8 0.0001
534 SPINAL OPERATION 1 0.0001
535 HYPERCALCAEMIA 1 0.0001
536 GENERALISED OEDEMA 1 0.0001
537 ILEUS 1 0.0001
538 HEPATIC FUNCTION ABNORMAL 3 0.0001
539 TOOTH EXTRACTION 1 0.0001
540 MUSCLE ATROPHY 1 0.0001
541 ACUTE KIDNEY INJURY 12 0.0001
542 INTRAOCULAR PRESSURE INCREASED 1 0.0001
543 MYDRIASIS 1 0.0001
544 ERECTILE DYSFUNCTION 2 0.0001
545 HAEMATOMA 2 0.0001
546 GASTRITIS 2 0.0001
547 OROPHARYNGEAL PAIN 7 0.0001
548 INFUSION RELATED REACTION 5 0.0001
549 BREAST CANCER FEMALE 2 0.0001
550 JAUNDICE 2 0.0001
551 DRY MOUTH 6 0.0001
552 UVEITIS 1 0.0001
553 LIMB INJURY 2 0.0001
554 TACHYPNOEA 1 0.0001
555 CONSTIPATION 16 0.0001
556 GINGIVAL BLEEDING 1 0.0001
557 SKIN LESION 2 0.0001
558 HAEMATOCHEZIA 4 0.0001
559 RESPIRATORY DISTRESS 2 0.0001
560 DIVERTICULITIS 2 0.0001
561 DEMENTIA 2 0.0001
562 MASS 1 0.0001
563 RENAL IMPAIRMENT 6 0.0001
564 MALAISE 31 0.0001
565 SEASONAL ALLERGY 1 0.0001
566 DIALYSIS 1 0.0001
567 SINUS TACHYCARDIA 1 0.0001
568 URINARY TRACT INFECTION 12 0.0001
569 RECTAL HAEMORRHAGE 3 0.0001
570 MOBILITY DECREASED 5 0.0001
571 BACK PAIN 16 0.0001
572 DYSSTASIA 2 0.0001
573 SKIN HAEMORRHAGE 1 0.0001
574 PULMONARY OEDEMA 3 0.0001
575 EPISTAXIS 5 0.0001
576 HYPOAESTHESIA ORAL 1 0.0001
577 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
578 OSTEOPENIA 1 0.0001
579 DIABETES MELLITUS 5 0.0001
580 INSURANCE ISSUE 1 0.0001
581 DEVICE RELATED INFECTION 1 0.0001
582 THYROID DISORDER 1 0.0001
583 GYNAECOMASTIA 2 0.0001
584 MUSCULOSKELETAL CHEST PAIN 1 0.0001
585 VISUAL IMPAIRMENT 8 0.0001
586 VOMITING 30 0.0001
587 DRUG-INDUCED LIVER INJURY 2 0.0001
588 PRODUCT USE COMPLAINT 1 0.0001
589 ARRHYTHMIA 3 0.0001
590 HEAD INJURY 2 0.0001
591 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
592 ULCER 1 0.0001
593 PRODUCTIVE COUGH 3 0.0001
594 SCIATICA 1 0.0001
595 ABSCESS 1 0.0001
596 CONFUSIONAL STATE 10 0.0001
597 BACK DISORDER 1 0.0001
598 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
599 HEMIPARESIS 1 0.0001
600 HOSPITALISATION 9 0.0001
601 PANCREATITIS 3 0.0001
602 DIARRHOEA 36 0.0001
603 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
604 OSTEOMYELITIS 1 0.0001
605 PELVIC PAIN 1 0.0001
606 THINKING ABNORMAL 1 0.0001
607 MIDDLE INSOMNIA 1 0.0001
608 PRODUCT USE ISSUE 10 0.0001
609 DEHYDRATION 7 0.0001
610 INCREASED APPETITE 1 0.0001
611 LOWER LIMB FRACTURE 1 0.0001
612 ACUTE RESPIRATORY FAILURE 1 0.0001
613 GLAUCOMA 1 0.0001
614 DRUG INTOLERANCE 5 0.0001
615 COVID-19 9 0.0001
616 CHOKING 1 0.0001
617 VISION BLURRED 7 0.0001
618 KIDNEY INFECTION 1 0.0001
619 DISORIENTATION 2 0.0001
620 UPPER LIMB FRACTURE 1 0.0001
621 PRESCRIBED UNDERDOSE 1 0.0001
622 PRODUCT PHYSICAL ISSUE 1 0.0000
623 FEEDING DISORDER 1 0.0000
624 BLINDNESS 2 0.0000
625 CHEST DISCOMFORT 5 0.0000
626 LUNG NEOPLASM MALIGNANT 2 0.0000
627 RIB FRACTURE 1 0.0000
628 CHEST PAIN 9 0.0000
629 TOOTH LOSS 1 0.0000
630 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
631 ABDOMINAL DISCOMFORT 8 0.0000
632 GAIT DISTURBANCE 9 0.0000
633 LOSS OF CONSCIOUSNESS 6 0.0000
634 LIVER FUNCTION TEST INCREASED 1 0.0000
635 POOR QUALITY SLEEP 1 0.0000
636 BALANCE DISORDER 4 0.0000
637 FAECES DISCOLOURED 1 0.0000
638 BLOOD CREATININE INCREASED 3 0.0000
639 MYOCARDIAL INFARCTION 8 0.0000
640 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
641 MUSCULOSKELETAL STIFFNESS 4 0.0000
642 MELAENA 1 0.0000
643 TOOTH DISORDER 1 0.0000
644 RASH MACULO-PAPULAR 1 0.0000
645 NEOPLASM MALIGNANT 3 0.0000
646 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
647 GASTROINTESTINAL DISORDER 4 0.0000
648 SNEEZING 1 0.0000
649 THERAPY NON-RESPONDER 2 0.0000
650 PAIN 27 0.0000
651 MEMORY IMPAIRMENT 6 0.0000
652 TINNITUS 2 0.0000
653 SHOCK 1 0.0000
654 RENAL DISORDER 2 0.0000
655 BREAST CANCER 4 0.0000
656 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
657 BLOOD GLUCOSE INCREASED 8 0.0000
658 FALL 14 0.0000
659 DISEASE RECURRENCE 2 0.0000
660 RASH ERYTHEMATOUS 2 0.0000
661 HEPATIC CANCER 1 0.0000
662 MENTAL IMPAIRMENT 1 0.0000
663 PRESYNCOPE 1 0.0000
664 NEURALGIA 1 0.0000
665 LIVER INJURY 1 0.0000
666 EXTRAPYRAMIDAL DISORDER 1 0.0000
667 CELLULITIS 2 0.0000
668 CHRONIC KIDNEY DISEASE 3 0.0000
669 HAEMATEMESIS 1 0.0000
670 CARDIOVASCULAR DISORDER 1 0.0000
671 FLUID RETENTION 2 0.0000
672 HEPATITIS 1 0.0000
673 DEAFNESS 1 0.0000
674 SPEECH DISORDER 2 0.0000
675 FEELING ABNORMAL 9 0.0000
676 CARDIAC FAILURE CONGESTIVE 3 0.0000
677 PAIN OF SKIN 1 0.0000
678 THROAT TIGHTNESS 1 0.0000
679 RASH PRURITIC 2 0.0000
680 OEDEMA 2 0.0000
681 PALLOR 1 0.0000
682 INFLUENZA LIKE ILLNESS 3 0.0000
683 CONDITION AGGRAVATED 11 0.0000
684 ARTHROPATHY 2 0.0000
685 FEELING COLD 1 0.0000
686 NECK PAIN 2 0.0000
687 PAIN IN JAW 1 0.0000
688 MYALGIA 6 0.0000
689 INTENTIONAL DOSE OMISSION 1 0.0000
690 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
691 ANGINA PECTORIS 1 0.0000
692 HYPERSOMNIA 1 0.0000
693 SOMNOLENCE 7 0.0000
694 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
695 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
696 LIVER FUNCTION TEST ABNORMAL 1 0.0000
697 PRODUCT STORAGE ERROR 3 0.0000
698 DYSPHONIA 2 0.0000
699 PALPITATIONS 4 0.0000
700 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
701 SURGERY 2 0.0000
702 INSOMNIA 9 0.0000
703 CATARACT 2 0.0000
704 ADVERSE DRUG REACTION 3 0.0000
705 APHASIA 1 0.0000
706 LACRIMATION INCREASED 1 0.0000
707 ILL-DEFINED DISORDER 2 0.0000
708 EPILEPSY 1 0.0000
709 ADVERSE EVENT 3 0.0000
710 FEMUR FRACTURE 1 0.0000
711 HEADACHE 20 0.0000
712 MOVEMENT DISORDER 1 0.0000
713 HIP FRACTURE 1 0.0000
714 LACTIC ACIDOSIS 1 0.0000
715 OSTEONECROSIS 1 0.0000
716 EYE DISORDER 1 0.0000
717 STAPHYLOCOCCAL INFECTION 1 0.0000
718 BLOOD PRESSURE DECREASED 2 0.0000
719 VIRAL INFECTION 1 0.0000
720 DRY SKIN 4 0.0000
721 TOXICITY TO VARIOUS AGENTS 5 0.0000
722 ABDOMINAL PAIN UPPER 6 0.0000
723 GASTRIC DISORDER 1 0.0000
724 ARTHRALGIA 12 0.0000
725 DELIRIUM 1 0.0000
726 HYPERKALAEMIA 1 0.0000
727 HEART RATE DECREASED 1 0.0000
728 SLEEP DISORDER 2 0.0000
729 INFECTION 4 0.0000
730 CRYING 1 0.0000
731 ACCIDENTAL OVERDOSE 1 0.0000
732 BRONCHITIS 2 0.0000
733 DYSARTHRIA 1 0.0000
734 HALLUCINATION 2 0.0000
735 INTESTINAL OBSTRUCTION 1 0.0000
736 PLASMA CELL MYELOMA 1 0.0000
737 ARTHRITIS 2 0.0000
738 PARAESTHESIA 4 0.0000
739 EXTRA DOSE ADMINISTERED 1 0.0000
740 OSTEOPOROSIS 1 0.0000
741 VAGINAL HAEMORRHAGE 1 0.0000
742 MENTAL DISORDER 1 0.0000
743 INTENTIONAL PRODUCT MISUSE 2 0.0000
744 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
745 ANGIOEDEMA 1 0.0000
746 RENAL FAILURE 3 0.0000
747 LIVER DISORDER 1 0.0000
748 TACHYCARDIA 2 0.0000
749 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
750 SUICIDAL IDEATION 2 0.0000
751 NEPHROLITHIASIS 1 0.0000
752 NASOPHARYNGITIS 4 0.0000
753 BLOOD CHOLESTEROL INCREASED 1 0.0000
754 COUGH 6 0.0000
755 COMA 1 0.0000
756 MIGRAINE 2 0.0000
757 BLOOD GLUCOSE DECREASED 1 0.0000
758 HEART RATE INCREASED 2 0.0000
759 HYPOAESTHESIA 3 0.0000
760 DRY EYE 1 0.0000
761 DRUG INEFFECTIVE 26 0.0000
762 PERIPHERAL SWELLING 3 0.0000
763 INFLAMMATION 1 0.0000
764 NERVOUSNESS 1 0.0000
765 MUSCULOSKELETAL PAIN 1 0.0000
766 DEPRESSED MOOD 1 0.0000
767 OVERDOSE 4 0.0000
768 RASH 8 0.0000
769 TREATMENT NONCOMPLIANCE 1 0.0000
770 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
771 ANAPHYLACTIC REACTION 1 0.0000
772 INFLUENZA 2 0.0000
773 EYE PAIN 1 0.0000
774 FLATULENCE 1 0.0000
775 DEPRESSION 4 0.0000
776 LETHARGY 1 0.0000
777 CHILLS 2 0.0000
778 WHEEZING 1 0.0000
779 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
780 OEDEMA PERIPHERAL 2 0.0000
781 DISCOMFORT 1 0.0000
782 MUSCLE SPASMS 3 0.0000
783 RHINORRHOEA 1 0.0000
784 HEPATIC ENZYME INCREASED 1 0.0000
785 BURNING SENSATION 1 0.0000
786 HYPERTENSION 3 0.0000
787 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
788 PAIN IN EXTREMITY 4 0.0000
789 UNEVALUABLE EVENT 1 0.0000
790 ACNE 1 0.0000
791 BLOOD PRESSURE INCREASED 2 0.0000
792 TREMOR 2 0.0000
793 CARDIAC DISORDER 1 0.0000
794 PRURITUS 4 0.0000
795 PRODUCT DOSE OMISSION ISSUE 3 0.0000
796 SINUSITIS 1 0.0000
797 ABDOMINAL DISTENSION 1 0.0000
798 WEIGHT INCREASED 2 0.0000
799 ASTHMA 1 0.0000
800 JOINT SWELLING 1 0.0000
801 ANXIETY 2 0.0000
802 URTICARIA 1 0.0000
803 NO ADVERSE EVENT 1 0.0000
804 HYPERSENSITIVITY 1 0.0000
805 INCORRECT DOSE ADMINISTERED 1 0.0000